Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirlene M Sampson

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Psychiatry Research. Neuroimaging|December 15, 2015
Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescentsPaul E Croarkin, Paul A Nakonezny, Christopher A Wall, et al.
Journal of Child and Adolescent Psychopharmacology|January 20, 2012
Increased cortical excitability with prefrontal high-frequency repetitive transcranial magnetic stimulation in adolescents with treatment-resistant major depressive disorderPaul E Croarkin, Christopher A Wall, Paul A Nakonezny, et al.
The Journal of Clinical Psychiatry|February 1, 2008
Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatmentPhilip G Janicak, John P O'Reardon, Shirlene M Sampson, et al.
Journal of Child and Adolescent Psychopharmacology|February 6, 2016
Magnetic Resonance Imaging-Guided, Open-Label, High-Frequency Repetitive Transcranial Magnetic Stimulation for Adolescents with Major Depressive DisorderChristopher A Wall, Paul E Croarkin, Mandie J Maroney-Smith, et al.
The Journal of Clinical Psychiatry|September 29, 2011
Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: a prospective, open pilot studyChristopher A Wall, Paul E Croarkin, Leslie A Sim, et al.
The Journal of Clinical Psychiatry|February 5, 2009
Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE)Keith G Rasmussen, Martina Mueller, Teresa A Rummans, et al.
The Journal of Clinical Psychiatry|December 7, 2007
Antidepressant medication treatment failure does not predict lower remission with ECT for major depressive disorder: a report from the consortium for research in electroconvulsive therapyKeith G Rasmussen, Martina Mueller, Rebecca G Knapp, et al.
The Journal of Clinical Psychiatry|February 26, 2008
Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trialDavid H Avery, Keith E Isenberg, Shirlene M Sampson, et al.
Psychiatry Research|January 22, 2005
Relationship between somatization and remission with ECTKeith G Rasmussen, Karen A Snyder, Rebecca G Knapp, et al.
Stereotactic and Functional Neurosurgery|April 20, 2016
Stimulation-Induced Transient Nonmotor Psychiatric Symptoms following Subthalamic Deep Brain Stimulation in Patients with Parkinson's Disease: Association with Clinical Outcomes and Neuroanatomical CorrelatesOsama A Abulseoud, Aimen Kasasbeh, Hoon-Ki Min, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Psychiatry Research. Neuroimaging|December 15, 2015
Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescentsPaul E Croarkin, Paul A Nakonezny, Christopher A Wall, et al.
Journal of Child and Adolescent Psychopharmacology|January 20, 2012
Increased cortical excitability with prefrontal high-frequency repetitive transcranial magnetic stimulation in adolescents with treatment-resistant major depressive disorderPaul E Croarkin, Christopher A Wall, Paul A Nakonezny, et al.
The Journal of Clinical Psychiatry|February 1, 2008
Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatmentPhilip G Janicak, John P O'Reardon, Shirlene M Sampson, et al.
Journal of Child and Adolescent Psychopharmacology|February 6, 2016
Magnetic Resonance Imaging-Guided, Open-Label, High-Frequency Repetitive Transcranial Magnetic Stimulation for Adolescents with Major Depressive DisorderChristopher A Wall, Paul E Croarkin, Mandie J Maroney-Smith, et al.
The Journal of Clinical Psychiatry|September 29, 2011
Adjunctive use of repetitive transcranial magnetic stimulation in depressed adolescents: a prospective, open pilot studyChristopher A Wall, Paul E Croarkin, Leslie A Sim, et al.
The Journal of Clinical Psychiatry|February 5, 2009
Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE)Keith G Rasmussen, Martina Mueller, Teresa A Rummans, et al.
The Journal of Clinical Psychiatry|December 7, 2007
Antidepressant medication treatment failure does not predict lower remission with ECT for major depressive disorder: a report from the consortium for research in electroconvulsive therapyKeith G Rasmussen, Martina Mueller, Rebecca G Knapp, et al.
The Journal of Clinical Psychiatry|February 26, 2008
Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trialDavid H Avery, Keith E Isenberg, Shirlene M Sampson, et al.
Psychiatry Research|January 22, 2005
Relationship between somatization and remission with ECTKeith G Rasmussen, Karen A Snyder, Rebecca G Knapp, et al.
Stereotactic and Functional Neurosurgery|April 20, 2016
Stimulation-Induced Transient Nonmotor Psychiatric Symptoms following Subthalamic Deep Brain Stimulation in Patients with Parkinson's Disease: Association with Clinical Outcomes and Neuroanatomical CorrelatesOsama A Abulseoud, Aimen Kasasbeh, Hoon-Ki Min, et al.
Pageof 3